| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |